Form 8-K - Current report:
SEC Accession No. 0001104659-25-024185
Filing Date
2025-03-17
Accepted
2025-03-17 07:05:27
Documents
13
Period of Report
2025-03-11
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm259415d1_8k.htm   iXBRL 8-K 28524
  Complete submission text file 0001104659-25-024185.txt   203947

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA coll-20250311.xsd EX-101.SCH 3036
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE coll-20250311_lab.xml EX-101.LAB 34240
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE coll-20250311_pre.xml EX-101.PRE 22373
15 EXTRACTED XBRL INSTANCE DOCUMENT tm259415d1_8k_htm.xml XML 3700
Mailing Address 100 TECHNOLOGY CENTER DRIVE STOUGHTON MA 02072
Business Address 100 TECHNOLOGY CENTER DRIVE STOUGHTON MA 02072 781-713-3699
COLLEGIUM PHARMACEUTICAL, INC (Filer) CIK: 0001267565 (see all company filings)

EIN.: 000000000 | State of Incorp.: VA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37372 | Film No.: 25742327
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)